Literature DB >> 24793001

Segmental testicular infarction due to minocycline-induced antineutrophil cytoplasmic antibody--positive vasculitis.

Timothy D Lyon1, Matthew C Ferroni2, Daniel P Casella2, Louis A D'Agostino2, Stephen V Jackman2.   

Abstract

Segmental testicular infarction is an uncommon clinical entity marked by acute scrotal pain and swelling. Classically, these appear as wedge-shaped, avascular, hypoechoic lesions on a testicular ultrasound. We present a unique case of testicular infarct caused by an antineutrophil cytoplasmic antibody-positive vasculitis secondary to the use of the antibiotic minocycline. The patient's symptoms resolved with cessation of minocycline. We suggest that patients who present with otherwise unexplained testicular infarction undergo a careful review of medications to uncover a potential cause.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24793001     DOI: 10.1016/j.urology.2014.03.011

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Testicular Pain Associated With Minocycline Use.

Authors:  Victor Kucherov; William Hulbert; Guan Wu
Journal:  Urol Case Rep       Date:  2015-03-02

2.  Testicular granulomatous vasculitis mimicking testicular torsion in an anti-neutrophil cytoplasmic antibody-associated vasculitis patient.

Authors:  Liye Suo; Luis Carlos Perez; Christie Jean Finch
Journal:  SAGE Open Med Case Rep       Date:  2019-01-16

Review 3.  Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.

Authors:  Rafael G Grau
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.686

4.  Scrotoscopy and traditional open surgery shows a high degree of consistency in the diagnosis of testicular torsion: An initial report.

Authors:  Huaishan Hong; Wanghai Cai; Jinfeng Wu; Xiang Wu; Le Lin; Tao Li; Qingguo Zhu; Yunliang Gao; Liefu Ye; Yongbao Wei; Jinrui Yang
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.